ClinicalTrials.Veeva
Menu

Find clinical trials for Triple Negative Breast Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Carcinoma
Endometrial Cancer
Ovarian Cancer

Triple Negative Breast Cancer trials near Salt Lake City, UT, USA:

Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma (MARIO-3)

oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...

Active, not recruiting
Breast Cancer
Renal Cell Carcinoma
Drug: nab-paclitaxel
Drug: Bevacizumab

Phase 2

Infinity Pharmaceuticals
Infinity Pharmaceuticals

Salt Lake City, Utah, United States and 23 other locations

escalation will be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer...

Enrolling
Metastatic Breast Cancer
Recurrent Ovarian Carcinoma
Drug: Belinostat
Drug: Ribociclib

Phase 1

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States and 1 other location

or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...

Enrolling
Triple Negative Breast Cancer
Drug: Capecitabine
Drug: Sacituzumab govitecan-hziy (SG)

Phase 3

Gilead Sciences
Gilead Sciences

Salt Lake City, Utah, United States and 224 other locations

to assess the safety, tolerability, and pharmacokinetics, and to identify the optimal dose of ADRX-0706 in patients with select advanced solid tumors...

Active, not recruiting
Triple Negative Breast Cancer (TNBC)
Urothelial Cancer
Drug: ADRX-0706

Phase 1

Adcentrx Therapeutics

West Valley City, Utah, United States of America and 20 other locations

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

Active, not recruiting
Triple Negative Breast Cancer
PD-L1 Positive
Drug: Pembrolizumab
Drug: Carboplatin

Phase 3

Gilead Sciences
Gilead Sciences

Salt Lake City, Utah, United States and 506 other locations

and tolerability of NKT5097 in adults with advanced/metastatic tumors (emphasis on breast cancer and solid tumors...

Enrolling
Endometrial Cancer
Triple Negative Breast Cancer (TNBC)
Drug: NKT5097 CDK2/CDK4 dual degrader

Phase 1

NiKang Therapeutics

West Valley City, Utah, United States and 5 other locations

This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....

Enrolling
Triple Negative Breast Cancer, TNBC
Small Cell Lung Cancer, SCLC
Drug: JAB-2485 (Aurora A inhibitor)

Phase 1, Phase 2

Jacobio Pharmaceuticals

Salt Lake City, Utah, United States and 4 other locations

This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...

Enrolling
Ovarian Neoplasms
Gastric Cancer
Drug: pembrolizumab
Drug: PF-08046054

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

West Valley City, Utah, United States of America and 55 other locations

Locations recently updated

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...

Enrolling
Gastric/Esophageal Cancer
Micro Satellite Stable Colorectal Cancer
Drug: Bevacizumab
Drug: Azirkitug

Phase 1

AbbVie
AbbVie

West Valley City, Utah, United States and 31 other locations

This study will test the safety, including side effects, and determine the characteristics of a drug called Rina-S in participants with solid tumors...

Enrolling
Uterine Cancer
Hormone Receptor-positive/Her2 Negative Breast Cancer
Drug: Carboplatin
Drug: Pembrolizumab

Phase 1, Phase 2

Genmab
Genmab

West Valley City, Utah, United States of America and 37 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems